Market Access Consulting & HEOR
Generate evidence to optimize access and enable commercial success.
You need clarity on your product’s value early. We generate robust evidence, demonstrating value to stakeholders. Partner with us to ensure your product meets regulatory, provider, payer, policymaker and patient expectations—optimizing your commercial opportunities.
Pursue outcomes, value and access initiatives
Develop a strategy and generate data to meet the needs of all stakeholders.
Enhance your commercial opportunities
Grow understanding of your product’s clinical, economic and patient-centered value, and generate evidence to increase your likelihood of access.
Work with an interdisciplinary team
Get tailored solutions to meet your product’s needs at every stage of development.
A forward-thinking approach to evidence and value
Are you in Phase I or looking ahead to late phase and post-approval? We help ensure your product’s policymakers and patients, identifying evidence gaps and creating custom projects to support your product. Using their expertise in epidemiology, real-world evidence, health economics, outcomes research, patient-centered assessment, biostatistics, reimbursement, access strategy and value demonstration, our market access and HEOR consultants craft strategies that highlight your product’s unique value.
Access a suite of complementary solutions
Enhance your value, evidence and access strategies with our comprehensive solutions:
- Real-world data (RWD) and real-world evidence (RWE)
- Post-hoc and payer-focused analytics
- Patient-centered research and assessment
- Health economics and modeling
- HTA strategy and submissions
- Value demonstration and communication
- Reimbursement strategy and payer insights
- Market access landscape assessment
- Digital and design solutions
- Digital health strategy
Work with an experienced collaborator
Being dependable and responsive – Fortrea’s Market Access Consulting & HEOR team has cultivated enduring relationships with leading organizations, maintaining client engagements that span over two decades, with several exceeding 10, 15, and even 25 years—demonstrating deep trust, consistent value delivery, and long-term strategic collaboration.
- Understand market access in your target regions to advise on strategy, evidence needs, and solutions
- Develop patient-centered endpoints to measure treatment benefit, per the FDA’s Patient-Focused Drug Development program
- Collect and analyze RWD on natural history, incidence/prevalence, effectiveness, and safety
- Conduct post-hoc analyses for economic modeling and payer reimbursement
- Identify your product’s key value attributes and determine post-registration evidence needs
- Create impactful communication tools to showcase your product’s value to market-access decision-makers
Insights
Get the latest updates on Market Access Consulting & HEOR
Pricing and reimbursement in Italy: At a glance
Pricing and reimbursement processes in Italy
Download Case Study
The power of real-world data in clinical development and post-market activities
Read The power of real-world data in clinical development and post-market activities
Strategic considerations when planning an externally controlled single-arm trial
Download White Paper
Why literature reviews should be a key part of your evidence-generation strategy
Download White Paper
Inflation Reduction Act (IRA): Assessing the implications of Medicare drug price negotiations for drug development sponsors
Download White Paper
Digital transformation in market access
Digital transformation is a grand phase—it can cover technological innovation, data and processes and even global organizational change, yet it doesn't have to be a daunting prospect left to those loooknig for systemic change at a company level.
Download Case Study